Dublin, July 29, 2024 (GLOBE NEWSWIRE) — The “U.S. Menopause Market Size, Share & Trends Analysis Report by Treatment (Dietary Supplements, OTC Pharma Products), and Segment Forecasts, 2024-2030” report has been added to ResearchAndMarkets.com’s offering.
The U.S. menopause market size is anticipated to reach USD 7.3 billion by 2030, growing at a CAGR of 4.8%
The rising aging women population worldwide reaching menopause and its related symptoms are resulting in a growing demand for menopause-related products, services, and treatments. In addition, the menopause market in the U.S. is expanding due to the rising inclination towards natural and organic menopause remedies. Furthermore, the market growth is also supported by the introduction of advanced products and technologies, such as hormone-free therapies and telemedicine services.
Lifestyle factors such as smoking, alcohol consumption, and obesity can exacerbate menopause symptoms, leading to an increased demand for menopause treatments. Women who lead unhealthy lifestyles are more likely to experience severe menopause symptoms, which is expected to drive the market’s growth. According to a study published by the National Library of Medicine, the risk of frequent or severe vasomotor symptoms increased significantly among obese smokers.
There has been a growing focus on personalized medicine, with treatments tailored to each patient’s individual needs However, several smaller companies specialize in niche areas of the market, such as alternative therapies or personalized medicine approaches. For instance, in March 2023, Blue Cross Blue Shield of Michigan and Blue Care Network introduced a women’s health solution to aid their members in transitioning into menopause.
A key feature of the Family Building and Women’s Health Support Solution is a digital app that provides personalized care, helping members identify symptoms, explore treatment options, connect with experts, and join peer communities for support.
U.S. Menopause Market Report Highlights
- Dietary supplements dominated the treatment segment with around 95% of the revenue share in 2023, owing to the increasing awareness, availability, and affordability of natural treatments and ingredients during the menopause stage
- Women are opting for non-hormonal treatments for menopause, such as herbal supplements, acupuncture, and cognitive-behavioral therapy, due to concerns about side effects and long-term health risks
- In January 2024, Dr. Reddy’s Laboratories Ltd. acquired MenoLabs, a portfolio of dietary supplements for women’s health, from Amyris, Inc. The U.S. Dr. Reddy’s now owns all seven MenoLabs supplements, which are designed to help with symptoms of perimenopause and menopause, including probiotics like MenoGlow, MenoFit, and Happy Fiber.
Companies Featured
- Pfizer Inc.
- Novo Nordisk A/S
- TherapeuticsMD
- Bayer AG
- AbbVie, Inc.
- Pure Encapsulations, LLC.
- PADAGIS LLC
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 80 |
| Forecast Period | 2023 – 2030 |
| Estimated Market Value (USD) in 2023 | $5.3 Billion |
| Forecasted Market Value (USD) by 2030 | $7.3 Billion |
| Compound Annual Growth Rate | 4.8% |
| Regions Covered | United States |
Key Topics Covered:
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.3. Research Methodology
1.4. Information Procurement
1.5. Information or Data Analysis
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Treatment outlook
2.3. Competitive Insights
Chapter 3. U.S. Menopause Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market restraint analysis
3.3. U.S. Menopause Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.2. PESTEL Analysis
Chapter 4. U.S. Menopause Market: Treatment Estimates & Trend Analysis
4.1. Form Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. U.S. Menopause Market by Treatment Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.4.1. Dietary Supplements
4.4.2. OTC Pharma Products
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.2. Hormonal
4.4.2.3. Non Hormonal
Chapter 5. Competitive Landscape
5.1. Recent Developments & Impact Analysis, By Key Market Participants
5.2. Company/Competition Categorization
5.3. Vendor Landscape
5.3.1. List of key distributors and channel partners
5.3.2. Key customers
5.3.3. Key company heat map analysis, 2023
5.4. Company Profiles
5.4.1. Company overview
5.4.2. Financial performance
5.4.3. Product benchmarking
5.4.4. Strategic initiatives
For more information about this report visit https://www.researchandmarkets.com/r/9b4dex
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
